Altimetrik has opened a healthcare and life sciences centre of excellence in Hyderabad, creating a dedicated facility for developing artificial intelligence solutions across drug discovery, clinical development, manufacturing, patient engagement and care delivery.
The centre operates from Altimetrik’s 22,000 sq ft office in Gachibowli, which has more than 300 employees. The company said the new facility brings together AI engineers and life sciences specialists to build industry-focused solutions for its global AI engineering delivery operations.
According to Altimetrik, the centre will work on AI agents designed to meet regulatory requirements, trace outputs to trusted sources and retain human accountability for decisions. The company did not disclose a separate headcount or investment figure for the new centre in the announcement reported by The Hindu.
The facility’s stated areas of work span the healthcare and life sciences value chain. These include drug discovery, clinical development, commercial operations, manufacturing, patient engagement and care delivery. The range places the centre within Hyderabad’s wider overlap between technology services, pharmaceutical research and healthcare operations.
Altimetrik said Hyderabad was selected because of its combination of pharmaceutical expertise and technology talent, along with the presence of pharmaceutical companies and contract research organisations. The city’s Gachibowli area has become an important location for technology and corporate offices, while Hyderabad also hosts a significant pharmaceutical and life sciences base.
The opening forms part of Altimetrik’s expansion in India. The company’s recent expansion in Pune took its global workforce beyond 11,000 employees, according to the report. The Hyderabad centre gives its India teams a dedicated industry-focused base for work connected to global clients and delivery programmes.
Raj Sundaresan, Altimetrik’s chief executive officer, said Hyderabad’s combination of life sciences capabilities and technology talent made it the right location for the centre. His statement linked the facility’s location to the city’s existing institutional and industry ecosystem rather than presenting it as a standalone office expansion.
The company’s emphasis on regulatory compliance, traceability and human accountability reflects the specific operating requirements of healthcare-related artificial intelligence. Unlike general-purpose technology applications, systems used across research, manufacturing and care delivery must operate within processes where decisions and outputs require oversight. Altimetrik’s announcement identified these requirements as part of the centre’s intended work.
The company has not announced a launch timeline for individual products, the number of AI agents to be developed or the expected employment increase linked specifically to the centre. For now, the confirmed development is the opening of the Hyderabad facility and its role in Altimetrik’s broader global AI engineering delivery network.
